Short answer
Coverage of GLP-1 medication for weight loss depends on your specific plan, not just your insurer. Medicare has covered some GLP-1 drugs for obesity since July 1, 2026 through a temporary program; Medicaid coverage depends on the state; TRICARE Prime and Select cover them with prior authorization. Always ask your plan for the written criteria.
Why your plan matters more than your insurer
Large insurers run many different plans — employer plans, individual marketplace plans, Medicare Advantage — and each has its own drug list (formulary). Two people with the same insurer can get different answers. Most plans that cover these drugs require prior authorization: approval from the plan before you fill the prescription.
Medicare
Since July 1, 2026, Medicare covers certain GLP-1 drugs for weight loss through the Medicare GLP-1 Bridge, a short-term program scheduled to run through December 31, 2027: Foundayo (tablet), Wegovy (injection or tablet) and the Zepbound KwikPen, with a $50 copay for a one-month supply, for people with Medicare drug coverage (Part D) who meet BMI and health criteria. Details in our Medicare, Medicaid and TRICARE guide.
Medicaid
Medicaid coverage of GLP-1s for obesity is decided by each state. KFF reports that only 13 states covered them as of January 2026. A federal model (BALANCE) lets states opt in from May 2026. Ask your state Medicaid plan.
TRICARE
TRICARE Prime and TRICARE Select cover weight loss medications (Wegovy, Zepbound, Contrave, Qsymia and phentermine) with an approved prior authorization. Since August 31, 2025 that coverage is no longer available to beneficiaries outside Prime and Select, including TRICARE For Life.
How to ask your plan
- Ask whether the specific drug is on the formulary for weight management (not only for diabetes).
- Ask for the prior-authorization criteria in writing (BMI, conditions, lifestyle program).
- Ask whether the clinic's visits are covered separately and if the clinic is in network.
- Ask what you would pay per month at a network pharmacy.
Insurance coverage checklist: print the questions.
What to ask a clinic before booking
A clinic that «accepts insurance» may bill your plan for visits while the medication is paid separately. Ask both questions. On every WeightMapGo listing we show whether the clinic's own website says it accepts insurance, with the date we read it.
Find a clinic
Some clinics whose website mentions this service (open your state for the full list):
- 360 WellnessAltoona, PA(814) 667-5820
- Medical weight management
- GLP-1 program
- Telehealth visits
- Nutrition counseling
- Bariatric surgery
- AZ Vitality and WellnessPeoria, AZ(602) 540-3547
- Medical weight management
- GLP-1 program
- Nutrition counseling
- AZ Weight & Metabolic HealthMesa, AZ(602) 638-1905
- Medical weight management
- GLP-1 program
- Telehealth visits
- Nutrition counseling
- Advanced Metabolic SolutionsAlexandria, LA(318) 321-1914
- Medical weight management
- GLP-1 program
- Telehealth visits
- Aly HealthOrlando, FL(888) 890-8692
- Medical weight management
- GLP-1 program
- Telehealth visits
- Nutrition counseling
- Bariatric surgery
Frequently asked questions
Is Ozempic covered for weight loss?
Ozempic is a diabetes medication. Plans that cover it for type 2 diabetes may not cover it for weight loss; ask your plan about drugs covered for weight management.
Will insurance cover a compounded GLP-1?
Ask your plan. The FDA states that compounded drugs are not FDA-approved.
Sources
- HealthCare.gov — Prior authorization (glossary) (accessed Nov 2, 2026)
- Medicare.gov — Weight loss drugs (accessed Nov 2, 2026)
- CMS — Medicare GLP-1 Bridge: information for Part D plans (accessed Nov 2, 2026)
- KFF — What to know about the BALANCE model for GLP-1s in Medicare and Medicaid (May 11, 2026) (accessed Nov 2, 2026)
- Express Scripts (TRICARE pharmacy) — Are GLP-1 and weight loss medications covered? (accessed Nov 2, 2026)
- FDA — FDA's concerns with unapproved GLP-1 drugs used for weight loss (accessed Nov 2, 2026)
Written by the WeightMapGo editorial team (editorial policy). Medical review: pending. Sources checked Nov 2, 2026. Spotted an error? Tell us.